David Arciniegas
Concepts (415)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 40 | 2023 | 468 | 7.550 |
Why?
| Cognition Disorders | 28 | 2016 | 504 | 3.610 |
Why?
| Brain Injuries, Traumatic | 13 | 2024 | 341 | 3.010 |
Why?
| Memory Disorders | 8 | 2024 | 168 | 2.310 |
Why?
| Neuropsychological Tests | 32 | 2024 | 1012 | 2.220 |
Why?
| Bipolar Disorder | 11 | 2023 | 235 | 2.020 |
Why?
| Neuropsychiatry | 6 | 2020 | 17 | 2.010 |
Why?
| Cholinesterase Inhibitors | 5 | 2024 | 29 | 1.820 |
Why?
| Neurosciences | 3 | 2017 | 29 | 1.460 |
Why?
| Mental Disorders | 18 | 2014 | 1030 | 1.390 |
Why?
| Indans | 2 | 2024 | 11 | 1.350 |
Why?
| Depressive Disorder, Major | 6 | 2023 | 345 | 1.200 |
Why?
| Piperidines | 2 | 2024 | 196 | 1.180 |
Why?
| Crying | 6 | 2014 | 15 | 1.100 |
Why?
| Mood Disorders | 6 | 2023 | 120 | 1.060 |
Why?
| Consciousness Disorders | 5 | 2023 | 19 | 1.050 |
Why?
| Brain | 21 | 2023 | 2678 | 1.010 |
Why?
| Affective Symptoms | 5 | 2014 | 51 | 0.990 |
Why?
| Frontotemporal Dementia | 2 | 2023 | 37 | 0.940 |
Why?
| Nootropic Agents | 1 | 2024 | 29 | 0.930 |
Why?
| Laughter | 5 | 2014 | 8 | 0.910 |
Why?
| Aggression | 4 | 2014 | 195 | 0.910 |
Why?
| Psychotic Disorders | 5 | 2015 | 151 | 0.900 |
Why?
| Hypoxia-Ischemia, Brain | 3 | 2010 | 34 | 0.860 |
Why?
| Consciousness | 1 | 2023 | 25 | 0.850 |
Why?
| Nervous System Diseases | 7 | 2020 | 252 | 0.830 |
Why?
| Memory | 7 | 2024 | 254 | 0.820 |
Why?
| Receptors, Cholinergic | 4 | 2011 | 38 | 0.820 |
Why?
| Humans | 125 | 2024 | 129378 | 0.780 |
Why?
| Lupus Erythematosus, Systemic | 8 | 2013 | 247 | 0.760 |
Why?
| Evoked Potentials, Auditory | 6 | 2004 | 179 | 0.730 |
Why?
| Forensic Psychiatry | 2 | 2013 | 27 | 0.710 |
Why?
| Psychiatry | 4 | 2016 | 179 | 0.710 |
Why?
| Functional Laterality | 8 | 2016 | 222 | 0.660 |
Why?
| Antipsychotic Agents | 4 | 2015 | 194 | 0.660 |
Why?
| Irritable Mood | 3 | 2022 | 49 | 0.650 |
Why?
| Hippocampus | 9 | 2019 | 874 | 0.640 |
Why?
| Alcoholism | 6 | 2022 | 766 | 0.640 |
Why?
| Psychomotor Performance | 5 | 2011 | 313 | 0.630 |
Why?
| Diagnosis, Differential | 16 | 2017 | 1428 | 0.630 |
Why?
| Hallucinations | 2 | 2016 | 29 | 0.620 |
Why?
| Amnesia | 3 | 2023 | 43 | 0.610 |
Why?
| Acetylcholine | 4 | 2011 | 186 | 0.610 |
Why?
| Psychiatric Status Rating Scales | 10 | 2015 | 529 | 0.610 |
Why?
| Autism Spectrum Disorder | 1 | 2023 | 385 | 0.600 |
Why?
| Brain Injury, Chronic | 2 | 2013 | 23 | 0.590 |
Why?
| Adult | 50 | 2024 | 35512 | 0.580 |
Why?
| Confusion | 2 | 2020 | 28 | 0.580 |
Why?
| Cholinergic Fibers | 3 | 2011 | 17 | 0.570 |
Why?
| Diffusion Tensor Imaging | 2 | 2024 | 76 | 0.560 |
Why?
| Severity of Illness Index | 12 | 2011 | 2737 | 0.560 |
Why?
| Aphasia | 2 | 2015 | 21 | 0.560 |
Why?
| Cognition | 7 | 2018 | 1120 | 0.550 |
Why?
| Neurology | 2 | 2010 | 103 | 0.550 |
Why?
| Dementia | 3 | 2013 | 227 | 0.540 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2014 | 236 | 0.520 |
Why?
| Attention | 9 | 2019 | 437 | 0.520 |
Why?
| Capgras Syndrome | 1 | 2016 | 3 | 0.510 |
Why?
| Politics | 1 | 2017 | 93 | 0.510 |
Why?
| Impulsive Behavior | 2 | 2014 | 128 | 0.510 |
Why?
| West Nile Fever | 2 | 2008 | 49 | 0.500 |
Why?
| Male | 64 | 2024 | 63595 | 0.500 |
Why?
| Expert Testimony | 2 | 2013 | 36 | 0.490 |
Why?
| Dopamine Agents | 2 | 2006 | 16 | 0.490 |
Why?
| Pseudobulbar Palsy | 2 | 2005 | 2 | 0.480 |
Why?
| Brain Concussion | 5 | 2023 | 548 | 0.480 |
Why?
| Journalism, Medical | 1 | 2015 | 5 | 0.480 |
Why?
| Stroke Rehabilitation | 2 | 2005 | 40 | 0.470 |
Why?
| Connectome | 3 | 2023 | 84 | 0.460 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2015 | 61 | 0.460 |
Why?
| Middle Aged | 39 | 2024 | 31102 | 0.450 |
Why?
| Recovery of Function | 5 | 2019 | 642 | 0.430 |
Why?
| Double-Blind Method | 6 | 2024 | 1876 | 0.430 |
Why?
| Psychotropic Drugs | 1 | 2014 | 69 | 0.420 |
Why?
| Electroencephalography | 4 | 2015 | 403 | 0.410 |
Why?
| Periodicals as Topic | 1 | 2016 | 204 | 0.410 |
Why?
| Neurotransmitter Agents | 3 | 2008 | 81 | 0.410 |
Why?
| Mental Status Schedule | 2 | 2010 | 34 | 0.410 |
Why?
| Behavioral Symptoms | 1 | 2013 | 41 | 0.400 |
Why?
| Football | 1 | 2013 | 78 | 0.400 |
Why?
| Magnetic Resonance Imaging | 19 | 2023 | 3398 | 0.390 |
Why?
| Phenylcarbamates | 2 | 2009 | 4 | 0.380 |
Why?
| Treatment Outcome | 14 | 2024 | 10195 | 0.380 |
Why?
| Schizophrenia | 4 | 2015 | 431 | 0.370 |
Why?
| Veterans | 4 | 2023 | 1397 | 0.360 |
Why?
| Female | 48 | 2024 | 68686 | 0.350 |
Why?
| Neuroprotective Agents | 2 | 2009 | 122 | 0.350 |
Why?
| Frontal Lobe | 3 | 2013 | 154 | 0.340 |
Why?
| Surveys and Questionnaires | 5 | 2023 | 5390 | 0.340 |
Why?
| Violence | 1 | 2013 | 240 | 0.340 |
Why?
| Capital Punishment | 1 | 2010 | 3 | 0.340 |
Why?
| Delirium | 2 | 2024 | 78 | 0.330 |
Why?
| Cerebral Cortex | 5 | 2019 | 436 | 0.320 |
Why?
| Public Policy | 1 | 2010 | 67 | 0.320 |
Why?
| Post-Concussion Syndrome | 3 | 2013 | 166 | 0.320 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2010 | 68 | 0.320 |
Why?
| Tomography, Emission-Computed, Single-Photon | 2 | 2015 | 76 | 0.310 |
Why?
| Reflex | 1 | 2009 | 65 | 0.300 |
Why?
| White Matter | 2 | 2024 | 136 | 0.300 |
Why?
| Insanity Defense | 1 | 2008 | 11 | 0.290 |
Why?
| Geriatric Assessment | 1 | 2010 | 205 | 0.290 |
Why?
| Neuroanatomy | 2 | 2023 | 9 | 0.290 |
Why?
| Dibenzothiazepines | 1 | 2007 | 17 | 0.290 |
Why?
| Amygdala | 3 | 2018 | 198 | 0.290 |
Why?
| Central Nervous System Stimulants | 4 | 2016 | 154 | 0.280 |
Why?
| Cognitive Dysfunction | 2 | 2024 | 345 | 0.280 |
Why?
| Alzheimer Disease | 3 | 2011 | 519 | 0.280 |
Why?
| Injury Severity Score | 5 | 2019 | 509 | 0.280 |
Why?
| Crime | 1 | 2008 | 57 | 0.280 |
Why?
| Depression | 4 | 2009 | 1304 | 0.280 |
Why?
| Rivastigmine | 3 | 2021 | 5 | 0.280 |
Why?
| Stroke | 5 | 2015 | 1067 | 0.280 |
Why?
| Aged | 16 | 2024 | 22052 | 0.270 |
Why?
| Affect | 4 | 2008 | 286 | 0.270 |
Why?
| Military Personnel | 2 | 2023 | 514 | 0.260 |
Why?
| Executive Function | 2 | 2016 | 431 | 0.260 |
Why?
| Adrenergic Agents | 1 | 2006 | 6 | 0.260 |
Why?
| Hiccup | 1 | 2006 | 3 | 0.260 |
Why?
| Methylphenidate | 3 | 2016 | 36 | 0.250 |
Why?
| Behavioral Sciences | 1 | 2006 | 10 | 0.250 |
Why?
| Suicide | 1 | 2013 | 579 | 0.250 |
Why?
| Clinical Trials as Topic | 2 | 2009 | 1004 | 0.250 |
Why?
| Physician-Patient Relations | 1 | 2010 | 537 | 0.250 |
Why?
| Hemiplegia | 1 | 2005 | 21 | 0.250 |
Why?
| Neuropsychology | 1 | 2006 | 34 | 0.240 |
Why?
| Physical Therapy Modalities | 2 | 2005 | 292 | 0.240 |
Why?
| Paresis | 1 | 2005 | 30 | 0.240 |
Why?
| Amantadine | 1 | 2004 | 6 | 0.240 |
Why?
| Psychosurgery | 1 | 2004 | 8 | 0.230 |
Why?
| Indians, North American | 2 | 2010 | 600 | 0.230 |
Why?
| Neurologic Examination | 5 | 2008 | 115 | 0.230 |
Why?
| Specialization | 1 | 2006 | 145 | 0.230 |
Why?
| Encephalitis, Herpes Simplex | 1 | 2004 | 21 | 0.230 |
Why?
| Motor Skills | 1 | 2005 | 92 | 0.230 |
Why?
| Upper Extremity | 1 | 2005 | 94 | 0.230 |
Why?
| Disability Evaluation | 3 | 2019 | 284 | 0.220 |
Why?
| Mental Competency | 1 | 2024 | 27 | 0.220 |
Why?
| Hospital Mortality | 1 | 2008 | 850 | 0.220 |
Why?
| Neuroimaging | 5 | 2019 | 279 | 0.220 |
Why?
| Healthy Aging | 1 | 2024 | 34 | 0.220 |
Why?
| Stress Disorders, Post-Traumatic | 4 | 2021 | 824 | 0.220 |
Why?
| Comorbidity | 3 | 2014 | 1546 | 0.220 |
Why?
| Critical Care | 1 | 2008 | 552 | 0.210 |
Why?
| Valproic Acid | 2 | 2022 | 47 | 0.210 |
Why?
| Research Design | 1 | 2009 | 1038 | 0.200 |
Why?
| Predictive Value of Tests | 5 | 2019 | 1945 | 0.200 |
Why?
| Myelin Sheath | 1 | 2024 | 160 | 0.200 |
Why?
| Analysis of Variance | 5 | 2007 | 1287 | 0.200 |
Why?
| Delusions | 2 | 2015 | 10 | 0.200 |
Why?
| Magnetoencephalography | 5 | 2011 | 128 | 0.190 |
Why?
| Emotions | 3 | 2019 | 537 | 0.180 |
Why?
| Exercise Therapy | 1 | 2005 | 412 | 0.180 |
Why?
| Regression Analysis | 5 | 2013 | 993 | 0.180 |
Why?
| Thalamus | 2 | 2018 | 100 | 0.180 |
Why?
| Central Nervous System Agents | 1 | 2000 | 5 | 0.180 |
Why?
| Dominance, Cerebral | 1 | 2000 | 53 | 0.180 |
Why?
| Electroconvulsive Therapy | 2 | 2014 | 12 | 0.170 |
Why?
| Mental Status and Dementia Tests | 1 | 2020 | 23 | 0.170 |
Why?
| Conversion Disorder | 1 | 2020 | 9 | 0.170 |
Why?
| Rehabilitation Centers | 1 | 2020 | 37 | 0.170 |
Why?
| Acceptance and Commitment Therapy | 1 | 2020 | 27 | 0.160 |
Why?
| Young Adult | 7 | 2024 | 12415 | 0.160 |
Why?
| Physical and Rehabilitation Medicine | 1 | 2020 | 30 | 0.160 |
Why?
| Brain Diseases | 1 | 2000 | 137 | 0.160 |
Why?
| Prisoners | 1 | 2021 | 141 | 0.160 |
Why?
| Adult Survivors of Child Adverse Events | 1 | 2019 | 12 | 0.160 |
Why?
| Chronic Traumatic Encephalopathy | 1 | 2019 | 14 | 0.160 |
Why?
| Glasgow Coma Scale | 2 | 2011 | 167 | 0.160 |
Why?
| Sensory Thresholds | 1 | 1999 | 32 | 0.150 |
Why?
| Hospitalization | 1 | 2008 | 2070 | 0.150 |
Why?
| Habenula | 1 | 2018 | 13 | 0.150 |
Why?
| Facial Expression | 1 | 2019 | 72 | 0.150 |
Why?
| Substance-Related Disorders | 2 | 2020 | 1022 | 0.150 |
Why?
| Prospective Studies | 6 | 2017 | 7111 | 0.150 |
Why?
| Magnetic Resonance Spectroscopy | 5 | 2013 | 539 | 0.150 |
Why?
| Lithium Compounds | 1 | 2018 | 11 | 0.150 |
Why?
| Sertraline | 2 | 2009 | 30 | 0.140 |
Why?
| Spatial Memory | 1 | 2017 | 24 | 0.140 |
Why?
| Suicidal Ideation | 2 | 2023 | 463 | 0.140 |
Why?
| Anxiety Disorders | 2 | 2014 | 354 | 0.130 |
Why?
| Aged, 80 and over | 4 | 2011 | 7069 | 0.130 |
Why?
| Biomechanical Phenomena | 2 | 2011 | 764 | 0.130 |
Why?
| Glutamic Acid | 2 | 2011 | 237 | 0.130 |
Why?
| Factor Analysis, Statistical | 1 | 2017 | 284 | 0.130 |
Why?
| Choline | 4 | 2013 | 124 | 0.130 |
Why?
| Prognosis | 4 | 2019 | 3791 | 0.130 |
Why?
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 19 | 0.130 |
Why?
| Reproducibility of Results | 4 | 2019 | 3079 | 0.130 |
Why?
| Encephalitis | 1 | 2017 | 133 | 0.130 |
Why?
| Aspartic Acid | 3 | 2011 | 81 | 0.120 |
Why?
| Evidence-Based Medicine | 2 | 2011 | 715 | 0.120 |
Why?
| Suicide, Attempted | 1 | 2018 | 349 | 0.120 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 96 | 0.110 |
Why?
| Behavior, Animal | 1 | 2017 | 508 | 0.110 |
Why?
| Case-Control Studies | 5 | 2011 | 3375 | 0.110 |
Why?
| Creatine | 2 | 2011 | 58 | 0.110 |
Why?
| Length of Stay | 2 | 2011 | 1124 | 0.110 |
Why?
| Terminology as Topic | 2 | 2008 | 204 | 0.110 |
Why?
| Leukoencephalopathies | 1 | 2013 | 21 | 0.100 |
Why?
| Volition | 2 | 2006 | 30 | 0.100 |
Why?
| Range of Motion, Articular | 2 | 2005 | 366 | 0.100 |
Why?
| Retrospective Studies | 7 | 2019 | 14498 | 0.100 |
Why?
| Hyperbaric Oxygenation | 1 | 2012 | 38 | 0.100 |
Why?
| Blast Injuries | 1 | 2012 | 45 | 0.100 |
Why?
| Inpatients | 2 | 2018 | 465 | 0.090 |
Why?
| Referral and Consultation | 3 | 2024 | 731 | 0.090 |
Why?
| Neurobiology | 1 | 2011 | 15 | 0.090 |
Why?
| Forensic Medicine | 1 | 2011 | 18 | 0.090 |
Why?
| Risk Assessment | 3 | 2011 | 3236 | 0.090 |
Why?
| Phenotype | 1 | 1999 | 3076 | 0.090 |
Why?
| Anxiety | 1 | 2017 | 962 | 0.090 |
Why?
| Cohort Studies | 4 | 2023 | 5414 | 0.090 |
Why?
| Trauma Severity Indices | 1 | 2011 | 104 | 0.090 |
Why?
| Delphi Technique | 2 | 2023 | 222 | 0.090 |
Why?
| Multiple Sclerosis | 2 | 2007 | 436 | 0.090 |
Why?
| Schizophrenic Psychology | 2 | 2002 | 94 | 0.090 |
Why?
| Antidepressive Agents | 2 | 2018 | 228 | 0.090 |
Why?
| Rest | 1 | 2011 | 120 | 0.090 |
Why?
| United States | 6 | 2023 | 13876 | 0.080 |
Why?
| Economics | 1 | 2010 | 9 | 0.080 |
Why?
| Supreme Court Decisions | 1 | 2010 | 11 | 0.080 |
Why?
| Language Disorders | 1 | 2010 | 34 | 0.080 |
Why?
| Evoked Potentials, Somatosensory | 2 | 1999 | 33 | 0.080 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2009 | 30 | 0.080 |
Why?
| Citalopram | 1 | 2009 | 30 | 0.080 |
Why?
| Capsules | 1 | 2009 | 40 | 0.080 |
Why?
| Atrophy | 2 | 2007 | 171 | 0.080 |
Why?
| International Classification of Diseases | 1 | 2010 | 122 | 0.080 |
Why?
| Time | 1 | 2009 | 75 | 0.080 |
Why?
| Patient Education as Topic | 1 | 2014 | 738 | 0.080 |
Why?
| Consensus | 2 | 2023 | 613 | 0.080 |
Why?
| Adolescent | 6 | 2019 | 20378 | 0.080 |
Why?
| Animals | 7 | 2017 | 35346 | 0.080 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 212 | 0.070 |
Why?
| Medical Records | 1 | 2009 | 171 | 0.070 |
Why?
| Neurochemistry | 1 | 2008 | 6 | 0.070 |
Why?
| Antibodies | 1 | 2010 | 398 | 0.070 |
Why?
| Dissociative Disorders | 1 | 2008 | 21 | 0.070 |
Why?
| Quetiapine Fumarate | 1 | 2007 | 22 | 0.070 |
Why?
| Presenilin-2 | 1 | 2007 | 4 | 0.070 |
Why?
| Prevalence | 2 | 2021 | 2560 | 0.070 |
Why?
| Presenilin-1 | 1 | 2007 | 31 | 0.070 |
Why?
| Research | 1 | 2011 | 416 | 0.070 |
Why?
| Tomography, X-Ray Computed | 3 | 2019 | 2528 | 0.070 |
Why?
| Receptors, Neurotransmitter | 1 | 2007 | 17 | 0.070 |
Why?
| Interpersonal Relations | 1 | 2010 | 391 | 0.070 |
Why?
| Motor Activity | 2 | 2017 | 676 | 0.070 |
Why?
| Wasting Disease, Chronic | 1 | 2007 | 24 | 0.070 |
Why?
| Incidence | 2 | 2011 | 2641 | 0.070 |
Why?
| Pilot Projects | 2 | 2010 | 1587 | 0.070 |
Why?
| Neurosecretory Systems | 1 | 2007 | 31 | 0.070 |
Why?
| Intelligence Tests | 1 | 2007 | 58 | 0.070 |
Why?
| Pituitary ACTH Hypersecretion | 1 | 2006 | 10 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2009 | 768 | 0.070 |
Why?
| Disease Management | 1 | 2010 | 586 | 0.070 |
Why?
| Sensitivity and Specificity | 1 | 2011 | 1835 | 0.070 |
Why?
| Gyrus Cinguli | 2 | 2023 | 79 | 0.070 |
Why?
| Expressed Emotion | 1 | 2006 | 17 | 0.070 |
Why?
| Lithium Carbonate | 1 | 2006 | 5 | 0.060 |
Why?
| Accidents, Traffic | 1 | 2007 | 186 | 0.060 |
Why?
| Biogenic Amines | 1 | 2006 | 4 | 0.060 |
Why?
| Demography | 1 | 2007 | 279 | 0.060 |
Why?
| Illusions | 1 | 2006 | 14 | 0.060 |
Why?
| Sex Factors | 2 | 2003 | 1966 | 0.060 |
Why?
| Medical History Taking | 1 | 2006 | 118 | 0.060 |
Why?
| Disease Progression | 2 | 2011 | 2626 | 0.060 |
Why?
| Education | 1 | 2006 | 100 | 0.060 |
Why?
| Age Factors | 2 | 2019 | 3144 | 0.060 |
Why?
| Restraint, Physical | 1 | 2005 | 68 | 0.060 |
Why?
| Patient Selection | 1 | 2009 | 662 | 0.060 |
Why?
| Benzodiazepines | 1 | 2006 | 135 | 0.060 |
Why?
| Health Surveys | 1 | 2007 | 494 | 0.060 |
Why?
| Diazepam | 1 | 2004 | 34 | 0.060 |
Why?
| Confidence Intervals | 1 | 2005 | 317 | 0.060 |
Why?
| History, Ancient | 1 | 2004 | 52 | 0.060 |
Why?
| History, 19th Century | 1 | 2004 | 57 | 0.060 |
Why?
| Probability | 1 | 2005 | 306 | 0.060 |
Why?
| Narcotics | 1 | 2004 | 47 | 0.060 |
Why?
| Arm | 1 | 2005 | 107 | 0.060 |
Why?
| Psychological Tests | 1 | 2005 | 133 | 0.060 |
Why?
| Hydrocortisone | 1 | 2006 | 306 | 0.060 |
Why?
| Demyelinating Diseases | 1 | 2004 | 84 | 0.060 |
Why?
| Physostigmine | 1 | 2004 | 12 | 0.060 |
Why?
| Age of Onset | 1 | 2006 | 495 | 0.060 |
Why?
| Nerve Net | 1 | 2007 | 260 | 0.060 |
Why?
| Cognitive Aging | 1 | 2024 | 16 | 0.060 |
Why?
| Diagnostic Errors | 1 | 2005 | 161 | 0.050 |
Why?
| Corpus Callosum | 1 | 2024 | 66 | 0.050 |
Why?
| Autoantibodies | 1 | 2011 | 1466 | 0.050 |
Why?
| Time Factors | 2 | 2007 | 6550 | 0.050 |
Why?
| North America | 1 | 2004 | 291 | 0.050 |
Why?
| Methadone | 1 | 2004 | 92 | 0.050 |
Why?
| Cytokines | 1 | 2011 | 2015 | 0.050 |
Why?
| Longitudinal Studies | 2 | 2023 | 2714 | 0.050 |
Why?
| History, 20th Century | 1 | 2004 | 290 | 0.050 |
Why?
| Electrophysiology | 1 | 2003 | 212 | 0.050 |
Why?
| Akinetic Mutism | 1 | 2003 | 2 | 0.050 |
Why?
| Cooperative Behavior | 2 | 2006 | 430 | 0.050 |
Why?
| Datasets as Topic | 1 | 2023 | 109 | 0.050 |
Why?
| Hypnotics and Sedatives | 1 | 2004 | 174 | 0.050 |
Why?
| Anticonvulsants | 1 | 2005 | 209 | 0.050 |
Why?
| Cerebral Arterial Diseases | 1 | 2003 | 48 | 0.050 |
Why?
| Physician's Role | 1 | 2004 | 206 | 0.050 |
Why?
| Fellowships and Scholarships | 1 | 2006 | 273 | 0.050 |
Why?
| Depressive Disorder | 1 | 2005 | 365 | 0.050 |
Why?
| Auditory Cortex | 1 | 2002 | 41 | 0.050 |
Why?
| Coronary Artery Bypass | 1 | 2004 | 222 | 0.050 |
Why?
| Geriatric Psychiatry | 1 | 2002 | 12 | 0.050 |
Why?
| Psychotherapy | 1 | 2003 | 157 | 0.050 |
Why?
| Interviews as Topic | 1 | 2005 | 717 | 0.050 |
Why?
| Acute Disease | 1 | 2004 | 978 | 0.050 |
Why?
| Unconsciousness | 1 | 2001 | 19 | 0.050 |
Why?
| Ambulatory Care | 1 | 2005 | 504 | 0.050 |
Why?
| Chronic Disease | 2 | 2005 | 1713 | 0.050 |
Why?
| Health Services for the Aged | 1 | 2002 | 72 | 0.050 |
Why?
| Transdermal Patch | 1 | 2021 | 15 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2011 | 4061 | 0.040 |
Why?
| Myelinolysis, Central Pontine | 1 | 2000 | 2 | 0.040 |
Why?
| Inflammation | 1 | 2011 | 2735 | 0.040 |
Why?
| Psychomotor Disorders | 1 | 2000 | 17 | 0.040 |
Why?
| Societies, Medical | 2 | 2020 | 747 | 0.040 |
Why?
| Prefrontal Cortex | 1 | 2023 | 305 | 0.040 |
Why?
| Rehabilitation Research | 1 | 2020 | 6 | 0.040 |
Why?
| Epilepsies, Partial | 1 | 2000 | 46 | 0.040 |
Why?
| Treatment Failure | 1 | 2021 | 339 | 0.040 |
Why?
| Syndrome | 1 | 2000 | 339 | 0.040 |
Why?
| Magnetics | 1 | 1999 | 44 | 0.040 |
Why?
| Curriculum | 1 | 2006 | 911 | 0.040 |
Why?
| Glasgow Outcome Scale | 1 | 2019 | 8 | 0.040 |
Why?
| Happiness | 1 | 2019 | 21 | 0.040 |
Why?
| Combined Modality Therapy | 2 | 2016 | 1204 | 0.040 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2000 | 144 | 0.040 |
Why?
| Patient Outcome Assessment | 1 | 2020 | 125 | 0.040 |
Why?
| Pituitary Gland | 1 | 1999 | 148 | 0.040 |
Why?
| Corpus Striatum | 1 | 2000 | 159 | 0.040 |
Why?
| Temporal Lobe | 1 | 2019 | 87 | 0.040 |
Why?
| Social Stigma | 1 | 2020 | 117 | 0.040 |
Why?
| Evoked Potentials | 1 | 2019 | 116 | 0.040 |
Why?
| Follow-Up Studies | 3 | 2018 | 4888 | 0.040 |
Why?
| Organ Size | 1 | 2019 | 447 | 0.040 |
Why?
| Reference Values | 1 | 2000 | 793 | 0.040 |
Why?
| Reaction Time | 1 | 2000 | 410 | 0.040 |
Why?
| Gliosis | 1 | 2017 | 28 | 0.040 |
Why?
| Maze Learning | 1 | 2017 | 104 | 0.040 |
Why?
| Patient Discharge | 1 | 2024 | 855 | 0.040 |
Why?
| Mass Screening | 1 | 2005 | 1148 | 0.030 |
Why?
| Coronary Artery Disease | 1 | 2004 | 679 | 0.030 |
Why?
| Gray Matter | 1 | 2018 | 81 | 0.030 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 1999 | 253 | 0.030 |
Why?
| Bayes Theorem | 1 | 2019 | 375 | 0.030 |
Why?
| Brain Chemistry | 2 | 2009 | 118 | 0.030 |
Why?
| Decision Making | 1 | 2024 | 849 | 0.030 |
Why?
| Models, Animal | 1 | 2017 | 375 | 0.030 |
Why?
| Astrocytes | 1 | 2017 | 201 | 0.030 |
Why?
| Fear | 1 | 2019 | 350 | 0.030 |
Why?
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 38 | 0.030 |
Why?
| Microglia | 1 | 2017 | 235 | 0.030 |
Why?
| Academic Medical Centers | 2 | 2010 | 481 | 0.030 |
Why?
| Recurrence | 1 | 2017 | 1005 | 0.030 |
Why?
| Software | 1 | 1999 | 607 | 0.030 |
Why?
| Biomarkers | 2 | 2011 | 3972 | 0.030 |
Why?
| Linear Models | 1 | 2016 | 819 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2015 | 286 | 0.030 |
Why?
| Aging | 1 | 2024 | 1776 | 0.030 |
Why?
| Multivariate Analysis | 2 | 2011 | 1501 | 0.030 |
Why?
| Colorado | 3 | 2011 | 4415 | 0.030 |
Why?
| Child | 2 | 2019 | 20868 | 0.030 |
Why?
| Risk Factors | 2 | 2004 | 9752 | 0.030 |
Why?
| Caregivers | 1 | 2020 | 814 | 0.020 |
Why?
| Postoperative Complications | 1 | 2004 | 2479 | 0.020 |
Why?
| Creatinine | 1 | 2013 | 490 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2011 | 515 | 0.020 |
Why?
| Memory, Short-Term | 1 | 2013 | 262 | 0.020 |
Why?
| Visual Perception | 1 | 2011 | 163 | 0.020 |
Why?
| Neurofibrillary Tangles | 1 | 2007 | 13 | 0.020 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2007 | 43 | 0.020 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2007 | 71 | 0.020 |
Why?
| Axons | 1 | 2009 | 191 | 0.020 |
Why?
| Pituitary Hormones, Anterior | 1 | 2007 | 7 | 0.020 |
Why?
| Disease Reservoirs | 1 | 2007 | 19 | 0.020 |
Why?
| Pituitary Gland, Anterior | 1 | 2007 | 39 | 0.020 |
Why?
| Brain Mapping | 1 | 2011 | 574 | 0.020 |
Why?
| Lupus Vasculitis, Central Nervous System | 1 | 2007 | 14 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2018 | 5061 | 0.020 |
Why?
| Fatal Outcome | 1 | 2007 | 300 | 0.020 |
Why?
| Prolactin | 1 | 2007 | 98 | 0.020 |
Why?
| Point Mutation | 1 | 2007 | 225 | 0.020 |
Why?
| Thyrotropin | 1 | 2007 | 109 | 0.020 |
Why?
| Introns | 1 | 2007 | 251 | 0.020 |
Why?
| Psychomotor Agitation | 1 | 2007 | 64 | 0.020 |
Why?
| Antiemetics | 1 | 2006 | 40 | 0.020 |
Why?
| Adrenocorticotropic Hormone | 1 | 2007 | 133 | 0.020 |
Why?
| Stereotyping | 1 | 2006 | 46 | 0.020 |
Why?
| Vomiting | 1 | 2006 | 126 | 0.020 |
Why?
| Skull | 1 | 2006 | 129 | 0.020 |
Why?
| Benzamides | 1 | 2006 | 207 | 0.020 |
Why?
| Verbal Behavior | 1 | 2005 | 46 | 0.020 |
Why?
| Mental Processes | 1 | 2005 | 38 | 0.020 |
Why?
| Mental Health Services | 1 | 2010 | 404 | 0.020 |
Why?
| Carbamazepine | 1 | 2005 | 19 | 0.020 |
Why?
| Saliva | 1 | 2006 | 209 | 0.010 |
Why?
| MEDLINE | 1 | 2005 | 20 | 0.010 |
Why?
| Central Nervous System Diseases | 1 | 2005 | 67 | 0.010 |
Why?
| Polymorphism, Genetic | 1 | 2007 | 640 | 0.010 |
Why?
| Central Nervous System | 1 | 2005 | 257 | 0.010 |
Why?
| Language | 1 | 2005 | 283 | 0.010 |
Why?
| Radiography | 1 | 2005 | 798 | 0.010 |
Why?
| Hospitals, Veterans | 1 | 2004 | 255 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2006 | 2011 | 0.010 |
Why?
| Brain Ischemia | 1 | 2005 | 321 | 0.010 |
Why?
| Pain | 1 | 2007 | 785 | 0.010 |
Why?
| Mice | 1 | 2017 | 16935 | 0.010 |
Why?
| Median Nerve | 1 | 1999 | 23 | 0.010 |
Why?
| Electric Stimulation | 1 | 1999 | 269 | 0.010 |
Why?
| Adrenal Cortex Hormones | 1 | 1999 | 520 | 0.010 |
Why?
|
|
Arciniegas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|